DALLAS, February 1, 2012 /PRNewswire/ --
The report "Biomarkers Market (Discovery Technologies, Applications & Indications) - Global Trends, Opportunities & Forecasts (2011 - 2020)", as the name suggests, analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia, and Rest of the World.
Browse market data tables and in-depth TOC on the "Biomarkers Market (Discovery Technologies, Applications & Indications) -Global Trends, Opportunities & Forecasts (2011 -2020)"http://www.marketsandmarkets.com/Market-Reports/biomarkers-advanced-technologies-and-global-market-43.html
Early buyers will receive 10% customization on reports.
Biomarkers are defined by Biomarkers Consortium as "Characteristics that are objectively measured and evaluated as indicators of normal biological processes, pathogenic processes, or pharmacologic responses to therapeutic intervention." Biomarkers are an active area of medical research and are showing a growth due to the potential they hold for targeted therapy or personalized medicine.
Biomarker caters the need of biopharmaceutical companies in drug discovery and development process and companion diagnostics. The global Biomarker market is estimated to grow at a CAGR of 14.40% during the study period (2011-2016).
In this report, the global biomarker market is studied by the biomarker discovery technologies, its application in drug discovery & development process, personalized medicine and molecular diagnostics across major indications such as oncology, cardiology, neurology and other indications which include arthr
Copyright©2010 PR Newswire.
All rights reserved